Učitavanje...
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Amyloid light chain (AL) amyloidosis is a systemic disease characterised by the aggregation of misfolded immunoglobulin light chain (LC), predominantly in the heart and kidneys, causing organ failure. If untreated, the median survival of patients with cardiac AL amyloidosis is 6 months from the onse...
Spremljeno u:
| Izdano u: | Heart |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566095/ https://ncbi.nlm.nih.gov/pubmed/28456755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2016-310704 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|